Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2051 | 2373 | 36.1 | 76% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
144 | 3 | ENDOCRINOLOGY & METABOLISM//PITUITARY ADENOMA//GROWTH HORMONE | 64198 |
380 | 2 | PITUITARY ADENOMA//ACROMEGALY//CRANIOPHARYNGIOMA | 17117 |
2051 | 1 | ACROMEGALY//PEGVISOMANT//SOMATOSTATIN ANALOGS | 2373 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ACROMEGALY | authKW | 5349294 | 35% | 51% | 820 |
2 | PEGVISOMANT | authKW | 889997 | 4% | 82% | 84 |
3 | SOMATOSTATIN ANALOGS | authKW | 308671 | 4% | 25% | 97 |
4 | PITUITARY | journal | 245342 | 5% | 17% | 114 |
5 | LANREOTIDE | authKW | 240163 | 2% | 33% | 57 |
6 | GROWTH HORMONE RECEPTOR ANTAGONIST | authKW | 185909 | 1% | 85% | 17 |
7 | SOMATOSTATIN ANALOGUES | authKW | 166796 | 3% | 19% | 69 |
8 | MOL CLIN ENDOCRINOL ONCOL | address | 166459 | 3% | 16% | 79 |
9 | OCTREOTIDE | authKW | 159834 | 6% | 9% | 146 |
10 | ACROMEGALIC CARDIOMYOPATHY | authKW | 128660 | 0% | 100% | 10 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 73084 | 67% | 0% | 1585 |
2 | Medicine, General & Internal | 1066 | 11% | 0% | 267 |
3 | Clinical Neurology | 113 | 5% | 0% | 110 |
4 | Surgery | 38 | 5% | 0% | 109 |
5 | Medicine, Research & Experimental | 35 | 3% | 0% | 64 |
6 | Gastroenterology & Hepatology | 22 | 2% | 0% | 42 |
7 | Cardiac & Cardiovascular System | 14 | 2% | 0% | 56 |
8 | Medical Laboratory Technology | 7 | 1% | 0% | 13 |
9 | Pharmacology & Pharmacy | 6 | 4% | 0% | 92 |
10 | Otorhinolaryngology | 6 | 1% | 0% | 18 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL CLIN ENDOCRINOL ONCOL | 166459 | 3% | 16% | 79 |
2 | ENDOCRINOL | 70990 | 21% | 1% | 501 |
3 | NORTHWEST PITUITARY | 59750 | 1% | 39% | 12 |
4 | ENDOCRINOL METABNEUROENDOCRINE UNIT | 48489 | 0% | 54% | 7 |
5 | ENDOCRINOL CHUS | 38598 | 0% | 100% | 3 |
6 | INVEST BIOMED ENFERMEDADES RARAS CIBER ER UNI | 38598 | 0% | 100% | 3 |
7 | PHARMACOKINET METAB SERV | 38598 | 0% | 100% | 3 |
8 | TEACHING HOSP BOGENHAUSEN | 38598 | 0% | 100% | 3 |
9 | SECT SPECIALIZED ENDOCRINOL | 33954 | 1% | 20% | 13 |
10 | PITUITARY ROTTERDAM | 29405 | 0% | 57% | 4 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PITUITARY | 245342 | 5% | 17% | 114 |
2 | CLINICAL ENDOCRINOLOGY | 99853 | 10% | 3% | 241 |
3 | EUROPEAN JOURNAL OF ENDOCRINOLOGY | 69324 | 7% | 3% | 167 |
4 | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 46920 | 12% | 1% | 294 |
5 | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | 26555 | 4% | 2% | 101 |
6 | GROWTH HORMONE & IGF RESEARCH | 19318 | 2% | 4% | 41 |
7 | ENDOCRINE JOURNAL | 9797 | 2% | 2% | 47 |
8 | ACTA ENDOCRINOLOGICA | 8153 | 2% | 1% | 50 |
9 | HORMONE RESEARCH | 6156 | 2% | 1% | 41 |
10 | ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA | 5562 | 1% | 2% | 22 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ACROMEGALY | 5349294 | 35% | 51% | 820 | Search ACROMEGALY | Search ACROMEGALY |
2 | PEGVISOMANT | 889997 | 4% | 82% | 84 | Search PEGVISOMANT | Search PEGVISOMANT |
3 | SOMATOSTATIN ANALOGS | 308671 | 4% | 25% | 97 | Search SOMATOSTATIN+ANALOGS | Search SOMATOSTATIN+ANALOGS |
4 | LANREOTIDE | 240163 | 2% | 33% | 57 | Search LANREOTIDE | Search LANREOTIDE |
5 | GROWTH HORMONE RECEPTOR ANTAGONIST | 185909 | 1% | 85% | 17 | Search GROWTH+HORMONE+RECEPTOR+ANTAGONIST | Search GROWTH+HORMONE+RECEPTOR+ANTAGONIST |
6 | SOMATOSTATIN ANALOGUES | 166796 | 3% | 19% | 69 | Search SOMATOSTATIN+ANALOGUES | Search SOMATOSTATIN+ANALOGUES |
7 | OCTREOTIDE | 159834 | 6% | 9% | 146 | Search OCTREOTIDE | Search OCTREOTIDE |
8 | ACROMEGALIC CARDIOMYOPATHY | 128660 | 0% | 100% | 10 | Search ACROMEGALIC+CARDIOMYOPATHY | Search ACROMEGALIC+CARDIOMYOPATHY |
9 | GROWTH HORMONE | 91936 | 9% | 3% | 224 | Search GROWTH+HORMONE | Search GROWTH+HORMONE |
10 | ACROMEGALY TREATMENT | 90062 | 0% | 100% | 7 | Search ACROMEGALY+TREATMENT | Search ACROMEGALY+TREATMENT |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KATZNELSON, L , LAWS, ER , MELMED, S , MOLITCH, ME , MURAD, MH , UTZ, A , WASS, JAH , (2014) ACROMEGALY: AN ENDOCRINE SOCIETY CLINICAL PRACTICE GUIDELINE.JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. VOL. 99. ISSUE 11. P. 3933 -3951 | 131 | 65% | 109 |
2 | CHANSON, P , (2016) MEDICAL TREATMENT OF ACROMEGALY WITH DOPAMINE AGONISTS OR SOMATOSTATIN ANALOGS.NEUROENDOCRINOLOGY. VOL. 103. ISSUE 1. P. 50 -58 | 83 | 89% | 11 |
3 | KATZNELSON, L , ATKINSON, JLD , COOK, DM , EZZAT, SZ , HAMRAHIAN, AH , MILLER, KK , (2011) AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND TREATMENT OF ACROMEGALY-2011 UPDATE.ENDOCRINE PRACTICE. VOL. 17. ISSUE . P. 1 -+ | 189 | 56% | 77 |
4 | CAPATINA, C , WASS, JAH , (2015) 60 YEARS OF NEUROENDOCRINOLOGY ACROMEGALY.JOURNAL OF ENDOCRINOLOGY. VOL. 226. ISSUE 2. P. T141 -T160 | 139 | 72% | 12 |
5 | COLAO, A , FERONE, D , MARZULLO, P , LOMBARDI, G , (2004) SYSTEMIC COMPLICATIONS OF ACROMEGALY: EPIDEMIOLOGY, PATHOGENESIS, AND MANAGEMENT.ENDOCRINE REVIEWS. VOL. 25. ISSUE 1. P. 102-152 | 185 | 48% | 523 |
6 | PLOCKINGER, U , (2012) MEDICAL THERAPY OF ACROMEGALY.INTERNATIONAL JOURNAL OF ENDOCRINOLOGY. VOL. . ISSUE . P. - | 138 | 79% | 9 |
7 | COZZI, R , ATTANASIO, R , (2012) OCTREOTIDE LONG-ACTING REPEATABLE FOR ACROMEGALY.EXPERT REVIEW OF CLINICAL PHARMACOLOGY. VOL. 5. ISSUE 2. P. 125-143 | 149 | 68% | 4 |
8 | GIUSTINA, A , KARAMOUZIS, I , PATELLI, I , MAZZIOTTI, G , (2013) OCTREOTIDE FOR ACROMEGALY TREATMENT: A REAPPRAISAL.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 14. ISSUE 17. P. 2433 -2447 | 112 | 82% | 9 |
9 | GIUSTINA, A , CHANSON, P , BRONSTEIN, MD , KLIBANSKI, A , LAMBERTS, S , CASANUEVA, FF , TRAINER, P , GHIGO, E , HO, K , MELMED, S , (2010) A CONSENSUS ON CRITERIA FOR CURE OF ACROMEGALY.JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. VOL. 95. ISSUE 7. P. 3141 -3148 | 73 | 79% | 310 |
10 | NEGGERS, SJCMM , MUHAMMAD, A , VAN DER LELY, AJ , (2016) PEGVISOMANT TREATMENT IN ACROMEGALY.NEUROENDOCRINOLOGY. VOL. 103. ISSUE 1. P. 59 -65 | 55 | 92% | 12 |
Classes with closest relation at Level 1 |